← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2021Last known activity
Jun 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (10)
- NCT05950061Sponsor investigatorPhase 3Jun 1, 2022
- NCT05950061Lead sponsorPhase 3Jun 1, 2022
- NCT05950061Reponsible party - principal investigatorPhase 3Jun 1, 2022
- NCT05950061Study directorPhase 3Jun 1, 2022
- NCT05950061OfficialPhase 3Jun 1, 2022
- NCT05469529Lead sponsorN/AApr 15, 2022
- NCT05469529Overall official - principal investigatorN/AApr 15, 2022
- NCT05469529Reponsible party - principal investigatorN/AApr 15, 2022
- NCT05958277Lead sponsorPhase 3Jun 1, 2021
- NCT05958277Reponsible party - principal investigatorPhase 3Jun 1, 2021
Details
- Last known activity
- Jun 1, 2022